This inventor holds 39 USPTO granted patents and 20 published patent applications and 29 EPO patents, primarily in Oligosaccharide Production. Top assignees: Chr. Hansen Hmo Gmbh, Jennewein Biotechnologie Gmbh, Chr. Hansen A/s. Active years: 2014-2026.
Location History:
- Aachen, DE (2014 - 2022)
- Bad Honnef, DE (2018 - 2024)
Company Filing History:
17 out of 17 
13 out of 13 
6 out of 190 
Years Active: 2014-2026
Areas of Expertise:
Title: Innovations and Contributions of Stefan Jennewein in Biotechnology
Introduction
Stefan Jennewein is a prominent inventor based in Bad Honnef, Germany, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 32 patents, Jennewein has focused primarily on the purification and production of oligosaccharides through innovative methods. His work continues to influence advancements in microbial fermentation processes.
Latest Patents
Among Jennewein's latest inventions is a patented method for the purification of lacto-N-neotetraose (LNnT) from carbohydrates obtained by microbial fermentation. This method is characterized by two membrane filtration steps utilizing different membranes, or a combination of membrane filtration and continuous chromatography. Additionally, he has developed a process utilizing glycosidases in the production and purification of desired oligosaccharides. This process is particularly notable for its efficient use in microbial fermentation with host microorganisms, including those expressing sugar catabolic pathway proteins to enhance purification efficiency.
Career Highlights
Throughout his career, Jennewein has worked with notable companies in the biotechnology sector, including Chr. Hansen HMO GmbH and Jennewein Biotechnologie GmbH. His expertise and innovation in the field have led to significant advancements in oligosaccharide production, demonstrating his commitment to enhancing biotechnological applications.
Collaborations
Stefan Jennewein has collaborated with esteemed colleagues, including Markus Helfrich and Julia Parkot. These partnerships have been instrumental in furthering research and development in oligosaccharide technology, contributing to a collaborative environment that fosters innovation.
Conclusion
Stefan Jennewein's inventive spirit and innovative methodologies have positioned him as a key figure in the biotechnology sector. His extensive patent portfolio reflects a deep commitment to enhancing production techniques for oligosaccharides, ultimately advancing the field. With continued efforts and collaborations, Jennewein is set to inspire future innovations within the industry.